Author + information
- Received May 24, 2010
- Revision received July 13, 2010
- Accepted July 15, 2010
- Published online September 1, 2010.
- Simon Biner, MD*,†,
- Asim M. Rafique, MD*,
- Pavel Goykhman, MD*,
- Ryan P. Morrissey, MD*,
- Jesse Naghi, MD* and
- Robert J. Siegel, MD*,* ()
- ↵*Reprint requests and correspondence:
Dr. Robert J. Siegel, Division of Cardiology/Heart Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Room 5623, Los Angeles, California 90048
Objectives The aim of this study was to evaluate the value of clinical and echo-Doppler parameters for the prognosis of unoperated severe aortic stenosis (AS).
Background Approximately one-third of severe, symptomatic AS patients are denied surgery. Risk stratification of unoperated AS is important to determine eligibility for percutaneous aortic valve replacement, an evolving treatment option for AS patients deemed suboptimal for surgical aortic valve replacement.
Methods We retrospectively compared clinical and echo-Doppler parameters between survivors and nonsurvivors of 125 patients with unoperated severe AS.
Results The 1-year survival rate was 62.4%. In univariate analysis, survivors compared with nonsurvivors were younger (80.0 ± 10.9 years vs. 84.9 ± 11.1 years, p = 0.02), had a greater left ventricular ejection fraction (LVEF) (55 ± 15% vs. 50 ± 16%, p = 0.042), a higher left ventricular stroke volume (63 ± 19 ml vs. 56 ± 13 ml, p = 0.015), a lower E/E′ ratio (12.19 ± 5.7 vs. 16.87 ± 7.43, p < 0.001), and a lower prevalence of E/E′ >15 (20% vs. 55%, p < 0.001). Symptomatic status was nonsignificantly different between survivors and nonsurvivors. In patients with an LVEF ≥50%, the subgroup with E/E′ ≤15 and with E/E′ >15 had a 73.8% and 47.8% 1-year survival rate, respectively (p = 0.027). In the patients with an LVEF <50%, the patients with E/E′ ≤15 and those with E/E′ >15 demonstrated a 70.6% and 22.3% 1-year survival rate, respectively (p = 0.003). In multivariate analysis, significant predictors of mortality were E/E′ >15 and a combination of E/E′ >15 and B-type natriuretic peptide >300 ng/ml: adjusted mortality risk 2.34 (95% confidence interval (CI) 1.27 to 4.33, p = 0.0072) and 2.59 (95% CI 1.21 to 5.55, p = 0.014), respectively.
Conclusions The E/E′ ratio is the single most predictive clinical and echo-Doppler parameter in the assessment of overall prognosis in patients with unoperated severe AS. LVEF was a significant predictor of survival only in the univariate analysis. B-type natriuretic peptide alone was not a predictor of prognosis in the study population. However, the combination of E/E′ and B-type natriuretic peptide is even more predictive of the 1-year prognosis.
- aortic stenosis
- aortic valve
- systolic and diastolic dysfunction
The authors report that they have no relationships to disclose. Drs. Biner and Rafique contributed equally to this work.
- Received May 24, 2010.
- Revision received July 13, 2010.
- Accepted July 15, 2010.
- American College of Cardiology Foundation